Tenatoprazole

structure in first source

Also Known As:

5-methoxy-2-(((4-methoxy-3,5-dimethylpyrid-2-yl)methyl)sulfinyl)-1H-imidazo(4,5-b)pyridine; 5-methyl-2((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl-imidazo(4,5-b)pyridine; TU 199; TU-199; TU199

Networked: 5 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Sulfur Compounds: 278
  - Sulfoxides: 23
    - 2-Pyridinylmethylsulfinylbenzimidazoles
      - Tenatoprazole: 5
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2-Pyridinylmethylsulfinylbenzimidazoles
      - Tenatoprazole: 5
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 2-Pyridinylmethylsulfinylbenzimidazoles
        Tenatoprazole: 5

Experts

1.	Cheng, Tao: 1 article (02/2021)
2.	Gu, Zhi-Han: 1 article (02/2021)
3.	Han, Tian-Yong: 1 article (02/2021)
4.	Liu, Bo-Fu: 1 article (02/2021)
5.	Pan, Pan: 1 article (02/2021)
6.	Yu, Haifang: 1 article (02/2021)
7.	Bhatt, Nejal M: 1 article (10/2018)
8.	Chavada, Vijay D: 1 article (10/2018)
9.	Sanyal, Mallika: 1 article (10/2018)
10.	Shrivastav, Pranav S: 1 article (10/2018)

Related Diseases

1.	Pancreatitis 02/26/2021 - "We will search the EMBASE, WANFANG DATA, Web of Knowledge, China National Knowledge Infrastructure, PubMed, ClinicalTrials.gov and Cochrane Library from inception to June 30,2021 to retrieve relevant studies using the search strategy: ("Proton pump inhibitors" OR "PPI" OR "PPIs" OR "Omeprazole" OR "Tenatoprazole" OR "Pantoprazole" OR "acid suppression therapy" OR "acid suppression drugs") AND ("pancreatitis" OR "pancreatitides"). "
2.	Vertigo (Positional Vertigo) 10/12/2018 - "In the present work thin layer chromatography (TLC) has been utilized to evaluate lipophilicity of 11 representative drugs, which included six proton pump inhibitors (omeprazole, pantoprazole, rabeprazole, lansoprazole, ilaprazole, and tenatoprazole), an anti-vertigo drug, betahistine, nonsteroidal anti-inflammatory drug, ibuprofen, anti-malarial drug, atovaquone, an anti-HIV agent, atazanavir and a hormonal drug, calcitriol. "
3.	Ulcer 03/01/1999 - "The results demonstrate that TU-199 potently inhibits the acid secretion and formation of ulcers in various experimental rat models via an inhibition of H+, K(+)-ATPase. "
4.	Stomach Ulcer (Gastric Ulcer) 12/21/2022 - "Tenatoprazole, a newly developed proton pump inhibitor candidate, was developed as an acid inhibitor for gastric acid hypersecretion disorders such as gastric ulcer and reflux esophagitis. "
5.	Peptic Ulcer (Peptic Ulcers) 03/01/1999 - "These findings suggest that TU-199 may have a beneficial effect against peptic ulcer disease in humans." 03/01/1999 - "Effects of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion and gastroduodenal ulcers in rats."

Related Drugs and Biologics

1.	Proton Pump Inhibitors
2.	Omeprazole (Prilosec)
3.	Acids
4.	Pantoprazole (Protonix)
5.	Lansoprazole (Prevacid)
6.	Rabeprazole (Aciphex)
7.	Atovaquone (Mepron)
8.	Anti-HIV Agents (AIDS Drugs)
9.	Indomethacin (Indometacin)
10.	Ibuprofen (Motrin)

Related Therapies and Procedures

1.	Therapeutics
2.	Ligation